Xiaoling Chi
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Liver Disease and Transplantation
- Liver Diseases and Immunity
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
-
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
- Epidemiology 25
- Liver Disease Diagnosis and Treatment 24
- Hepatitis B Virus Studies 17
- Hepatology 19
- Hepatitis C virus research 11
- Hepatocellular Carcinoma Treatment and Prognosis 3
- Liver Diseases and Immunity 3
- Co-authors
- Huanming Xiao (22 shared papers)Xueen Liu (3 shared papers)Hui Zhuang (3 shared papers)Ming Hong (1 shared paper)Shaoling Li (1 shared paper)Lei Song (1 shared paper)Ming Lin (7 shared papers)Qi Wang (1 shared paper)
- Journals
- International Immunopharmacology (2 papers)Frontiers in Pharmacology (2 papers)Evidence-based Complementary and Alternative Medicine (2 papers)Journal of Viral Hepatitis (1 paper)Scientific Reports (1 paper)
- Partner nations
- ChinaItalyUnited Kingdom
In The Last Decade
Xiaoling Chi
29 papers receiving 297 citations
Peers
Comparison fields: 5 of 63
- Hepatology 157
- Epidemiology 202
- Pharmacology 17
- Pathology and Forensic Medicine 23
- Endocrinology, Diabetes and Metabolism 19
Countries citing papers authored by Xiaoling Chi
This map shows the geographic impact of Xiaoling Chi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Chi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Chi more than expected).
Fields of papers citing papers by Xiaoling Chi
This network shows the impact of papers produced by Xiaoling Chi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Chi. The network helps show where Xiaoling Chi may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoling Chi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 62 | |
| 2 | 2021 | 43 | |
| 3 | 2020 | 31 | |
| 4 | 2021 | 20 | |
| 5 | 2018 | 16 | |
| 6 | 2020 | 16 | |
| 7 | 2020 | 13 | |
| 8 | 2021 | 11 | |
| 9 | 2021 | 9 | |
| 10 | 2022 | 9 | |
| 11 | 2019 | 8 | |
| 12 | 2023 | 8 | |
| 13 | 2021 | 7 | |
| 14 | 2022 | 7 | |
| 15 | 2024 | 5 | |
| 16 | 2016 | 5 | |
| 17 | 2024 | 4 | |
| 18 | 2016 | 4 | |
| 19 | 2018 | 4 | |
| 20 | 2023 | 3 |
About Xiaoling Chi
Xiaoling Chi is a scholar working on Epidemiology, Hepatology, Surgery, Cardiology and Cardiovascular Medicine and Molecular Biology, having authored 31 papers that have together received 299 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (24 papers), Hepatitis B Virus Studies (17 papers), Hepatitis C virus research (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Liver Diseases and Immunity (3 papers), Diet, Metabolism, and Disease (2 papers), Pancreatitis Pathology and Treatment (2 papers) and Lipid metabolism and disorders (2 papers). The work is most often cited by research in Hepatology (157 citations), Epidemiology (202 citations), Pharmacology (17 citations), Pathology and Forensic Medicine (23 citations) and Endocrinology, Diabetes and Metabolism (19 citations). Xiaoling Chi has collaborated with scholars based in China, Italy and United Kingdom. Frequent co-authors include Huanming Xiao, Xueen Liu, Hui Zhuang, Ming Hong, Shaoling Li, Lei Song, Ming Lin, Qi Wang, Cong Yang and Yi Luo. Their work appears in journals such as International Immunopharmacology, Frontiers in Pharmacology, Evidence-based Complementary and Alternative Medicine, Journal of Viral Hepatitis and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.